Lamivudine + Stavudine Tablet 150/30 Mg

Lamivudine + Stavudine Tablet 150/30 Mg is a fixed-dose antiretroviral medication used in the treatment and long-term management of Human Immunodeficiency Virus (HIV) infection. This combination belongs to the nucleoside reverse transcriptase inhibitor (NRTI) class and is commonly prescribed as part of combination antiretroviral therapy (ART). Lamivudine and stavudine both work by inhibiting the HIV reverse transcriptase enzyme, which is essential for viral replication.

This pharmaceutical product helps reduce HIV viral load, supports immune system recovery, and slows the progression of HIV to AIDS when taken consistently under medical supervision. Lamivudine (150 mg) + Stavudine (30 mg) Tablet has been widely used in adult and pediatric HIV treatment regimens based on clinical assessment and treatment guidelines.

This product ensures consistent potency, safety, and therapeutic effectiveness. The oral tablet formulation allows easy administration and supports long-term treatment adherence. While it does not cure HIV, this antiretroviral product plays an important role in comprehensive HIV management and helps improve quality of life when used exactly as prescribed by a healthcare professional.

Product Features

• Contains Lamivudine 150mg and Stavudine 30mg combination
• Belongs to the nucleoside reverse transcriptase inhibitor (NRTI) class
• Used as part of a combination antiretroviral therapy (ART)
• Helps suppress HIV replication and control viral load
• Oral tablet formulation for convenient dosing
• Manufactured under strict pharmaceutical quality standards

How It Helps

• Inhibits HIV reverse transcriptase enzyme to stop viral replication
• Helps reduce HIV viral load in the bloodstream
• Supports immune system strength and recovery
• Slows the progression of HIV infection with regular use